Mind Medicine (MindMed) (MNMD) Stock Analysis

What Mind Medicine (MindMed) does

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain. Furthermore, MM-110, an a3ß4 nicotinic cholinergic receptor antagonist, has successfully completed Phase 1 studies for managing opioid withdrawal. The company's portfolio also includes MM-402, an R-enantiomer of 3,4-methylenedioxymethamphetamine, aimed at treating the core symptoms associated with autism spectrum disorder. Its corporate headquarters are situated in Vancouver, Canada.

Key metrics

ETFs linked to MNMD

Broad-market and Healthcare sector ETFs an investor holding Mind Medicine (MindMed) is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MNMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Mind Medicine (MindMed)?

Mind Medicine (MindMed) trades under the ticker MNMD on NASDAQ.

Which exchange is MNMD listed on?

MNMD is listed on NASDAQ.

What sector does Mind Medicine (MindMed) operate in?

Mind Medicine (MindMed) is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MNMD in a portfolio?

PortView shows MNMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.